Results 81 to 90 of about 44,359 (240)
Introducción y objetivos: los stents convencionales presentan tasas de restenosis intrastent entre 10% y 60%, mientras los stents liberadores de fármacos alcanzan el 10%. Para Latinoamérica, no hay reportes de restenosis intrastent en comparación con los
Jorge A Arroyave C, Magda C Cepeda G
doaj
The Restenosis “Antitheory” [PDF]
Within the field of interventional cardiology, the foremost challenge is to find an effective treatment to prevent restenosis. In the United States, more than 400,000 patients underwent a percutaneous coronary intervention procedure in 1992; more than a third of these patients will have recur rence of luminal narrowing. Since the first angioplasty was
openaire +2 more sources
Evidence supporting the use of serial intralesional steroid injections (ILSIs) as an adjunct therapy for patients with idiopathic subglottic stenosis (iSGS) remains inconclusive. In our prospective study of 75 patients with iSGS, ILSI use was associated with a significantly reduced risk of recurrence (hazard ratio = 0.20; 95% confidence interval 0.08–0.
Shengjie Ying+17 more
wiley +1 more source
Carotid artery restenosis after index carotid artery revascularization reduces its stroke prevention benefit. A 73-year-old woman presented with recurrent right carotid artery restenosis following two carotid endarterectomies with patch angioplasty and ...
Marianna Pavlyha, MD+2 more
doaj +1 more source
Aim.To analyze the literature data about the role of adiponectin, P-selectin and integrin β3 in the pathogenesis of the development of in-stent restenosis in patients with coronary heart disease after coronary stenting, as well as the possibility of ...
Chernyak A. A., Snezhitskiy V. A.
doaj +1 more source
Transcriptomic Features of Recurrence Rates in Idiopathic Subglottic Stenosis
Idiopathic subglottic stenosis (iSGS) is a rare disease that can lead to potentially life‐threatening shortness of breath. For most patients, iSGS is a chronic, recurrent disease, and rates of recurrence can differ markedly between patients. Using RNA sequencing, we found that patients with high recurrence rates exhibited transcriptional markers of an ...
Shengjie Ying+20 more
wiley +1 more source
Association of insulin resistance, insulin and leptin levels with coronary in-stent restenosis
Background: In-stent restenosis remains the major limitation of coronary stent implantation. Leptin is a hormone strongly related to insulin resistance (IR).
Amira Shoukry+2 more
doaj +1 more source
Abstract Aims Data about long‐term clinical outcomes of revascularization procedures, especially for autologous cell therapy (ACT), in diabetic patients with chronic limb‐threatening ischaemia (CLTI) are lacking. The aim of our study was to compare the mortality and amputation rates in patients with diabetic foot ulcers (DFU) and CLTI treated by ACT ...
M. Dubský+8 more
wiley +1 more source
Background: In the era of drug-eluting stents, although bare-metal stent (BMS) remains an option for percutaneous coronary intervention (PCI), restenosis remains the Achilles' heel of BMS implantation. A recent study demonstrated several pleiotropic anti-
Wen-Cheng Liu+9 more
doaj +1 more source
An engineered in vitro platform mimicking stent strut cross‐sectional shapes reveals how geometry influences cell behavior. Sharp‐cornered geometries promote cell proliferation and matrix alignment, while rounded shapes reduce these effects. The findings align with clinical outcomes and suggest intracellular tension as a key driver, offering a ...
Emmie J.D. Schoutens+5 more
wiley +1 more source